BTC

Benton Capital Corp. (TSX VENTURE:BTC) ("Benton" or "the Company") is pleased to
announce that it has signed a binding letter of intent ("LOI") to acquire a 100%
interest in Folium Life Science Inc ("Folium"), a private company, with its head
office located in Abbotsford, British Columbia.


Folium, through business partnerships and patient programs, has strategically
positioned itself to be the leader in the Medical Marijuana industry. An
application to become a Licensed Producer (LP) under the Marihuana for Medical
Purposes Regulations (MMPR) has been submitted to Health Canada and is currently
under final review. 


Pursuant to the LOI, Benton will acquire all of the shares of Folium from the
Folium shareholders in exchange for 13.5 million common shares of Benton. Upon
completion of the transaction Folium will become a wholly owned subsidiary of
Benton.


A summary of the key terms of the LOI with Folium is as follows:



--  Benton to issue 13.5 million common shares (post consolidation) to
    Folium upon closing; 
--  Prior to closing: 
    i.  Benton will be required to complete a share consolidation on a 2:1
        basis; 
    ii. Benton will distribute its shareholdings of Coro Mining Corp.
        ("Coro") to Benton shareholders through a return of capital
        transaction (see below for further details); and 
    iii.Benton will be required to complete a financing and to have a
        minimum $4.0 million on deposit after closing. 
--  Benton and Folium to each be satisfied with due diligence to be
    conducted over a 30 day due diligence period. 
--  Closing subject to Folium receiving its Right to Build approval from
    Health Canada to become a Licensed Producer. 
--  Benton to obtain all applicable regulatory and shareholder approvals. 
--  Management of Benton are required to enter into a voting support
    agreement pursuant to which they will vote their shares of Benton in
    support of the transactions set out in the LOI. 
--  Folium to nominate three members for election to Benton's Board of
    Director's. 
--  Fonda Betts, President and CEO of Folium will assume the position of
    President of Benton and; 
--  Following the closing of the acquisition of Folium: 
    i.  the funds in the treasury will be utilized to construct a production
        facility with a view of being fully licensed and in production by
        the end of the fourth quarter of 2014 and; 
    ii. the necessary steps will be taken to change the name of Benton
        Capital Corp. to Folium Life Science 



Prior to closing the acquisition of Folium, the Company will, through a return
of capital transaction, transfer all of its shareholdings in Coro consisting of
61 million common shares of Coro to its current shareholders on a pro-rata
basis. The transfer of the Coro shares directly to our shareholders will provide
the shareholders with the right to participate directly in the success of this
South American-focused copper company that has both stellar management and
excellent projects and partners. The Benton team will continue to support Coro
and fully believes that Coro will emerge as a successful developer of quality
economic copper projects. By providing the Benton shareholders with direct
ownership of the Coro shares, the discount that has resulted from Benton holding
the Coro share block should be eliminated. Moreover, the acquisition of Folium
will bring new value to the Benton shareholders through exposure to an emerging
and anticipated billion dollar commercial Medical Marijuana industry.


Stephen Stares, Company President and CEO commented "This is a tremendous
opportunity for our shareholders as they will not only receive their pro-rata
share of Coro Mining but will gain exposure to this emerging and potential
billion dollar industry led by experienced professionals that have directly
assisted Health Canada in building the framework and regulations applicable to
the Medical Marijuana industry in Canada for well over a decade." 


Benton will continue to update shareholders as the acquisition of Folium
progresses. 


About Folium Life Science Inc.:

Folium Life Science Inc. is a private company incorporated under the Business
Corporations Act (British Columbia), which carries on business exclusively in
the Medical Marijuana sector. Folium's head office is located in Abbotsford,
British Columbia. Folium has planned and negotiated for a production and
distribution facility outside of Victoria, BC. Folium's application to become a
Licensed Commercial Producer under Health Canada's Marihuana for Medical Purpose
Regulations (MMPR) is currently under final review by Health Canada.


Folium Life Science Inc. Management Team

FONDA BETTS - President & Chief Executive Officer and Board Member

Ms. Betts studied Operations Management and has over 20 years business
experience with a proven track record in marketing, retail operations,
manufacturing and business administration. Ms. Betts's strong entrepreneurial
drive has established her as a pioneer in the hydroponic industry. Her
background includes: co-founding a large retail chain of hydroponic outlets;
co-founding a national wholesale and garden supplies company (Allie's); and
co-founding Grotek Manufacturing which introduced one of Canada's most prominent
fertilizer brands. Ms. Betts was ranked in the top 100 (20th) of Canadian
businesswoman in 2004 as published in Profit magazine and Chatelaine. 


In 2009 her energy focused on the Canadian medical marijuana market. She became
a partner and CEO of MedicalMarijuana.ca and Maple Reef Plant Products, then
co-founded the Greenleaf Medical Clinic Ltd., which opened in Abbotsford B.C. in
November 2011.  


CHAD CLELLAND - Vice President of Production and Director 

Mr. Clelland, with over 15 years direct experience, has played a significant
role in the Canadian medical marijuana community. He co-founded the Medical
Marijuana Group in 2009, with the purchase of the MedicalMarijuana.ca website.
He has developed this site into an unsurpassed cornerstone of business activity
within the industry. 


Mr. Clelland has extensive industry knowledge and experience and has worked with
countless patients and licensed designated growers. He has successfully
contributed to properly identifying specific cannabis strains according to
patients' medical conditions. Through Maple Reef Plant Products, Mr. Clelland
has been integral in developing superior growing methods through efficient room
design and feed programs. 


Over the last few years Mr. Clelland has been part of a private stakeholders
group within Health Canada's Medical Marihuana Reform Division through the
Office of Controlled Substances and Tobacco Directorate. Mr. Clelland is a
strong supporter of patients' rights and access to affordable medication. It was
through these private closed-door meetings that the new Marihuana for Medical
Purposes were created. 


Mr. Clelland has certification in the Workers Compensation Board Occupational
Health & Safety Committee Training and Hazard Recognition and Control. He has
received certification from the Paramedic Academy and has completed the
accredited Fire Fighter levels 1 & 2 through the Justice Institute of B.C. Mr.
Clelland also holds a certificate in Integrated Pest Management issued by the
British Columbia Ministry of Environment. 


EDWARD CUMMINGS - Vice President of Operations and Director

Mr. Cummings has had notable business success through his founding of Get Smart
Ventures which involves land development, new construction and the sale of used
homes. Prior to Get Smart, he founded and operated a reputable landscaping and
irrigation company. Mr. Cummings has a strong business sense and a high level of
expertise in both project and operational management. 


In 2009, Mr. Cummings became involved in the MedicalMarijuana.ca Group of
Companies as an investor and subsequently began a more active role in the day to
day operations of the companies. Utilizing his project management experience,
Mr. Cummings was instrumental in developing and operating the
MedicalMarijuana.ca Group of Company's grow facilities. He continues to lead
staff in best practices and continuous improvement. His land development and
construction back ground has proved invaluable in planning and developing the
new licensed commercial production facility. 


PAUL BOBROSKY, CGA - Vice President Finance and Board Member

Mr. Bobrosky studied at the University of Calgary and earned his professional
accounting designation (Certified General Accountant) in 2006. Mr. Bobrosky has
over 20 years accounting experience with a diverse range of organizations across
multiple industries, the majority of which have been in controller and other
senior management and consulting roles. His work history includes experience
with both service and manufacturing companies within the oil and gas industry;
project accounting and controls with large EPCM and architectural firms;
acquiring and developing businesses with a private venture capitalist; and two
years in public practice with a CGA firm. 


Mr. Bobrosky has extensive experience with system implementations; internal
controls and process improvement; financial and management reporting; and
business development. Mr. Bobrosky has worked with the Medical Marijuana Group
of Companies since their inception in 2009.


About Benton Capital Corp.:

The Company currently has approximately $1.6 million in cash. In addition to the
cash, the Company holds 61,000,000 shares (approximately 38%) of Coro Mining
Corp. ("Coro"), currently valued at $6.1 million (based on the April 10, 2014
closing market price of $0.10 per Coro share) resulting in an approximate net
asset value of $7.7 million but a market capitalization of less than $4.6
million (based on Benton's closing price on April 10, 2014 of $0.06 per share).
The Company also holds 1,566,623 warrants of Coro exercisable at $0.15 until
December 20, 2016. In addition, Benton holds no debt and has a very low burn
rate. Benton also holds the Goodchild-PGM-Copper-Nickel project located less
than 4km from Stillwater's Marathon Copper-PGM deposit which is currently under
development near Marathon Ontario.


On behalf of the Board of Directors of Benton Capital Corp, 

Stephen Stares, President and CEO

THE TSX VENTURE EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE.


The information contained herein contains "forward-looking statements" within
the meaning of applicable securities legislation. Forward-looking statements
relate to information that is based on assumptions of management, forecasts of
future results, and estimates of amounts not yet determinable. Any statements
that express predictions, expectations, beliefs, plans, projections, objectives,
assumptions or future events or performance are not statements of historical
fact and may be "forward-looking statements". 


Forward-looking statements are subject to a variety of risks and uncertainties
which could cause actual events or results to differ from those reflected in the
forward-looking statements, including, without limitation: risks related to
failure to obtain adequate financing on a timely basis and on acceptable terms;
risks related to the outcome of legal proceedings; political and regulatory
risks associated with mining and exploration; risks related to the maintenance
of stock exchange listings; risks related to environmental regulation and
liability; the potential for delays in exploration or development activities or
the completion of feasibility studies; the uncertainty of profitability; risks
and uncertainties relating to the interpretation of drill results, the geology,
grade and continuity of mineral deposits; risks related to the inherent
uncertainty of production and cost estimates and the potential for unexpected
costs and expenses; results of prefeasibility and feasibility studies, and the
possibility that future exploration, development or mining results will not be
consistent with the Company's expectations; risks related to gold price and
other commodity price fluctuations; and other risks and uncertainties related to
the Company's prospects, properties and business detailed elsewhere in the
Company's disclosure record. Should one or more of these risks and uncertainties
materialize, or should underlying assumptions prove incorrect, actual results
may vary materially from those described in forward-looking statements.
Investors are cautioned against attributing undue certainty to forward-looking
statements. These forward looking statements are made as of the date hereof and
the Company does not assume any obligation to update or revise them to reflect
new events or circumstances. Actual events or results could differ materially
from the Company's expectations or projections. 


FOR FURTHER INFORMATION PLEASE CONTACT: 
Benton Capital Corp.
Stephen Stares
President and CEO
(807) 475-7474
(807) 475-7200 (FAX)


Benton Capital Corp.
3250 Highway 130
Rosslyn, ON P7K 0B1
www.bentoncapital.ca

Benton Capital Corp. (TSXV:BTC)
Historical Stock Chart
From Apr 2024 to May 2024

Benton Capital Corp. (TSXV:BTC)
Historical Stock Chart
From May 2023 to May 2024